BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23429496)

  • 1. Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma.
    Ko YH; Cho YS; Won HS; Jeon EK; An HJ; Hong SU; Park JH; Lee MA
    Pancreas; 2013 Jul; 42(5):829-35. PubMed ID: 23429496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma.
    Qu B; Yao L; Ma HL; Chen HL; Zhang Z; Xie J
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):37-43. PubMed ID: 28224423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma.
    Kim HS; Lee SH; Do SI; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2011 Apr; 207(4):247-52. PubMed ID: 21420796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of clinicopathological features and apoptosis inhibitor proteins in pancreas ductal adenocarcinoma.
    Argon A; Nart D; Oruç N; Coker A; Ozütemiz O
    Acta Gastroenterol Belg; 2014 Jun; 77(2):229-34. PubMed ID: 25090821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.
    Zhang J; Jiang X; Zhang J
    World J Surg Oncol; 2014 Mar; 12():49. PubMed ID: 24581082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C
    PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.
    Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K
    Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
    Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
    J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.
    Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y
    Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
    Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
    Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.